BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36113828)

  • 1. Asia-Pacific Colorectal Screening Score Combined With Stool DNA Test Improves the Detection Rate for Colorectal Advanced Neoplasms.
    Xu J; Rong L; Gu F; You P; Ding H; Zhai H; Wang B; Li Y; Ma X; Yin F; Yang L; He Y; Sheng J; Jin P
    Clin Gastroenterol Hepatol; 2023 Jun; 21(6):1627-1636.e4. PubMed ID: 36113828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy comparison among high risk factors questionnaire and Asia-Pacific colorectal screening score and their combinations with fecal immunochemical test in screening advanced colorectal tumor].
    Zhu N; Huang YQ; Song YM; Zhang SZ; Zheng S; Yuan Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Jul; 25(7):612-620. PubMed ID: 35844124
    [No Abstract]   [Full Text] [Related]  

  • 3. A Risk-Scoring System Combined With a Fecal Immunochemical Test Is Effective in Screening High-Risk Subjects for Early Colonoscopy to Detect Advanced Colorectal Neoplasms.
    Chiu HM; Ching JY; Wu KC; Rerknimitr R; Li J; Wu DC; Goh KL; Matsuda T; Kim HS; Leong R; Yeoh KG; Chong VH; Sollano JD; Ahmed F; Menon J; Sung JJ;
    Gastroenterology; 2016 Mar; 150(3):617-625.e3. PubMed ID: 26627608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Performance of Two Stool DNA Tests and a Fecal Immunochemical Test in Detecting Colorectal Neoplasm: A Multicenter Diagnostic Study.
    Jin P; You P; Fang J; Kang Q; Gu F; Cai Y; Zhai H; Wang B; Li Y; Xu J; Wang J; He Y; Wang Y; Dai M; Sheng J
    Cancer Epidemiol Biomarkers Prev; 2022 Mar; 31(3):654-661. PubMed ID: 34933958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying the optimal strategy for screening of advanced colorectal neoplasia.
    Jung YS; Park CH; Kim NH; Park JH; Park DI; Sohn CI
    J Gastroenterol Hepatol; 2017 May; 32(5):1003-1010. PubMed ID: 28449340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of Asia-Pacific colorectal screening score and evaluation of its use combined with fecal immunochemical test.
    He XX; Yuan SY; Li WB; Yang H; Ji W; Wang ZQ; Hao JY; Chen C; Chen WQ; Gao YX; Li LB; Cheng KL; Qian JM; Wang L; Li JN
    BMC Gastroenterol; 2019 Dec; 19(1):226. PubMed ID: 31881948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Preliminary application of the Asia-Pacific colorectal screening score combined with the quantitative fecal occult blood in colorectal neoplasia screening].
    Kang Q; Li N; Wang RF; Yang L; Jin P; Sheng JQ
    Zhonghua Yi Xue Za Zhi; 2021 Dec; 101(46):3825-3828. PubMed ID: 34895425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A combination of clinical risk stratification and fecal immunochemical test results to prioritize colonoscopy screening in asymptomatic participants.
    Aniwan S; Rerknimitr R; Kongkam P; Wisedopas N; Ponuthai Y; Chaithongrat S; Kullavanijaya P
    Gastrointest Endosc; 2015 Mar; 81(3):719-27. PubMed ID: 25708760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colorectal cancer screening using a stool DNA-based SDC2 methylation test: a multicenter, prospective trial.
    Kim CW; Kim H; Kim HR; Kye BH; Kim HJ; Min BS; Oh TJ; An S; Lee SH
    BMC Gastroenterol; 2021 Apr; 21(1):173. PubMed ID: 33858326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Comparison of Single and Combined Schemes of Asia-Pacific Colorectal Screening, Faecal Immunochemical and Stool Deoxyribonucleic Acid Testing for Community Colorectal Cancer Screening.
    Ze Y; Tu H; Zhang L; Bai Y; Ren Y; Chen X; Xue Y; Sun R; Yang Y; Yang J; Zhou X; Liu L
    J Multidiscip Healthc; 2023; 16():571-586. PubMed ID: 36883167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A combination of clinical risk stratification and fecal immunochemical test is useful for identifying persons with high priority of early colonoscopy.
    Jung YS; Park CH; Kim NH; Park JH; Park DI; Sohn CI
    Dig Liver Dis; 2018 Mar; 50(3):254-259. PubMed ID: 29198569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimizing Positivity Thresholds for a Risk-Adapted Screening Strategy in Colorectal Cancer Screening.
    Lu M; Wang L; Zhang Y; Liu C; Lu B; Du L; Liao X; Dong D; Wei D; Gao Y; Shi J; Ren J; Chen H; Dai M
    Clin Transl Gastroenterol; 2021 Aug; 12(8):e00398. PubMed ID: 34397041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Application study of stool-based methylated SDC2 test in the screening of colorectal neoplasms for physical examination population].
    Wang L; Huang ZM; Jiang YY; Zhu M; Zhang N; Xiong FB; Zou HZ; Xu XH
    Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Dec; 56(12):1767-1773. PubMed ID: 36536564
    [No Abstract]   [Full Text] [Related]  

  • 14. Early Detection of Colorectal Cancer: a Multi-Center Pre-Clinical Case Cohort Study for Validation of a Combined DNA Stool Test.
    Dollinger MM; Behl S; Fleig WE
    Clin Lab; 2018 Oct; 64(10):1719-1730. PubMed ID: 30336540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The multitarget fecal immunochemical test versus the fecal immunochemical test for programmatic colorectal cancer screening: a cross-sectional intervention study with paired design.
    Wisse PHA; de Klaver W; van Wifferen F; Meiqari L; Bierkens M; Greuter MJE; Carvalho B; van Leerdam ME; Spaander MCW; Dekker E; Coupé VMH; de Wit M; Meijer GA
    BMC Cancer; 2022 Dec; 22(1):1299. PubMed ID: 36503495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Sex, Age, and Positivity Threshold on Fecal Immunochemical Test Accuracy: A Systematic Review and Meta-analysis.
    Selby K; Levine EH; Doan C; Gies A; Brenner H; Quesenberry C; Lee JK; Corley DA
    Gastroenterology; 2019 Dec; 157(6):1494-1505. PubMed ID: 31472152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Asia-Pacific Colorectal Screening score: a validated tool that stratifies risk for colorectal advanced neoplasia in asymptomatic Asian subjects.
    Yeoh KG; Ho KY; Chiu HM; Zhu F; Ching JY; Wu DC; Matsuda T; Byeon JS; Lee SK; Goh KL; Sollano J; Rerknimitr R; Leong R; Tsoi K; Lin JT; Sung JJ;
    Gut; 2011 Sep; 60(9):1236-41. PubMed ID: 21402615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fresh vs Frozen Samples and Ambient Temperature Have Little Effect on Detection of Colorectal Cancer or Adenomas by a Fecal Immunochemical Test in a Colorectal Cancer Screening Cohort in Germany.
    Chen H; Werner S; Brenner H
    Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1547-1556.e5. PubMed ID: 27793749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The second round of the Dutch colorectal cancer screening program: Impact of an increased fecal immunochemical test cut-off level on yield of screening.
    Kooyker AI; Toes-Zoutendijk E; Opstal-van Winden AWJ; Spaander MCW; Buskermolen M; van Vuuren HJ; Kuipers EJ; van Kemenade FJ; Ramakers C; Thomeer MGJ; Dekker E; Nagtegaal ID; de Koning HJ; van Leerdam ME; Lansdorp-Vogelaar I
    Int J Cancer; 2020 Aug; 147(4):1098-1106. PubMed ID: 31853977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of the Asia-Pacific colorectal screening score and its modified versions in predicting colorectal advanced neoplasia in Chinese population.
    Kong Y; Zhuo L; Dong D; Zhuo L; Lou P; Cai T; Chen S; Pan J; Gao Y; Lu H; Ma Y; Dong Z; Luo X; Zhao H
    BMC Cancer; 2022 Sep; 22(1):961. PubMed ID: 36071414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.